Burcon Nutrascience Corporation
BU.TO
TSX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 490.26% | 332.70% | 186.43% | 13.02% | 101.09% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 490.26% | 332.70% | 186.43% | 13.02% | 101.09% |
| Cost of Revenue | 685.25% | 925.37% | 1,159.43% | 1,202.13% | -- |
| Gross Profit | -773.09% | -1,557.22% | -3,983.38% | -1,175.26% | -547.02% |
| SG&A Expenses | -22.55% | -25.96% | -21.52% | -15.10% | 1.17% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 69.21% | 42.32% | 21.48% | 16.50% | 8.83% |
| Operating Income | -48.20% | -29.38% | -15.56% | -16.71% | -6.39% |
| Income Before Tax | -77.69% | -56.86% | -30.17% | -29.70% | -7.60% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -72.98% | -56.86% | -30.17% | -29.70% | -7.60% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -72.98% | -56.86% | -30.17% | -29.70% | -7.60% |
| EBIT | -48.20% | -29.38% | -15.56% | -16.71% | -6.39% |
| EBITDA | -23.25% | -17.61% | -16.27% | -16.99% | -6.10% |
| EPS Basic | -4.36% | 10.70% | 19.68% | 9.02% | 14.96% |
| Normalized Basic EPS | -7.18% | 10.71% | 19.69% | 9.04% | 14.97% |
| EPS Diluted | -4.36% | 10.70% | 19.68% | 9.02% | 14.96% |
| Normalized Diluted EPS | -7.18% | 10.71% | 19.69% | 9.04% | 14.97% |
| Average Basic Shares Outstanding | 63.22% | 73.24% | 59.17% | 43.74% | 28.46% |
| Average Diluted Shares Outstanding | 63.22% | 73.24% | 59.17% | 43.74% | 28.46% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |